DERMTECH ANNOUNCES INCLUSION OF NON-INVASIVE GENOMIC PATCH TESTING IN THE NATIONAL COMPREHENSIVE CANCER NETWORK® (NCCN) CUTANEOUS MELANOMA GUIDELINES